SWX:SIGN
SWX:SIGNPackaging

Why SIG Group (SWX:SIGN) Is Down 31.4% After Dividend Pause and Profit Warning—And What's Next

Earlier this week, SIG Group announced a profit warning for 2025, projecting slightly negative to flat revenue growth and pausing its cash dividend as part of a broader transformation program. This shift reflects SIG Group's increased focus on capital discipline and plans to divest smaller non-aseptic businesses while pursuing a performance improvement program. We’ll explore how the pause in SIG’s cash dividend could alter the company’s investment narrative and analysts’ assumptions going...
SWX:BAER
SWX:BAERCapital Markets

Assessing Julius Baer (SWX:BAER) Valuation as Investors Revisit Shares in a Quiet Market

Julius Bär Gruppe (SWX:BAER) is back in the spotlight after its shares caught the attention of investors this week. There was no headline-generating event or earnings shock to explain the market’s latest move; sometimes the lack of obvious news can be just as telling. Whether you are already holding Julius Bär or scanning for hidden opportunities, moments like these often invite a closer look at what the market might be signaling under the surface. Over the year, Julius Bär Gruppe’s share...
SWX:MOBN
SWX:MOBNReal Estate

How Mobimo’s Meggen Site Acquisition (SWX:MOBN) Is Shaping Its Central Switzerland Investment Story

On September 1, 2025, Mobimo Holding AG acquired a 12,000 m² site in Meggen near Lake Lucerne, with plans to develop approximately 70 condominium units valued at CHF 120 million. The development taps into one of Central Switzerland’s most sought-after residential markets, further building on Mobimo’s track record in the region. We’ll explore how this significant pipeline expansion in an attractive location could shape Mobimo’s broader investment narrative. These 9 companies survived and...
SWX:MOVE
SWX:MOVEMedical Equipment

Does Medacta Group’s Growth Guidance and Innovation Push Strengthen Analyst Confidence in SWX:MOVE?

Medacta Group SA recently reported strong half-year earnings, with sales reaching €344.14 million and net income rising to €60.04 million, while confirming 2025 guidance targeting 16% to 18% revenue growth in constant currency. Alongside these financial results, the company continued to expand its Personalized Sports Medicine Portfolio, launching the QuickStitch device at a major industry congress, highlighting ongoing investment in innovation and physician education. We'll examine how...
SWX:GALD
SWX:GALDPharmaceuticals

Galderma (SWX:GALD): Evaluating Valuation in Light of New Sensitive Skin Research and Upcoming EADV Data Presentations

If you have been watching Galderma Group (SWX:GALD), the company’s latest research announcement may have caught your attention. Galderma just unveiled new real-world clinical data examining how modern lifestyles and environmental factors impact people with sensitive skin, and it is preparing to spotlight 12 fresh research presentations at Europe’s largest dermatology congress this month. For current and prospective investors, this move emphasizes Galderma’s determination to underpin its...
SWX:ALC
SWX:ALCMedical Equipment

Should Efficiency Gains From UNITY VCS Prompt Action From Alcon (SWX:ALC) Investors?

Alcon recently announced results from time and motion studies showing that its UNITY® Vitreoretinal Cataract System (VCS) delivers measurable efficiency gains in vitreoretinal and cataract surgeries compared to established systems, with findings presented at major ophthalmology congresses in September 2025. The studies highlight Alcon’s commitment to addressing global challenges in eye care, particularly as the rising prevalence of conditions like age-related macular degeneration and...
SWX:BALN
SWX:BALNInsurance

Is Improved Half-Year Profitability Altering the Investment Case for Baloise Holding (SWX:BALN)?

Baloise Holding AG announced its half-year 2025 results last week, reporting net income of CHF 275.9 million and basic earnings per share of CHF 6.08, both higher than the prior year. This earnings improvement highlights stronger operational performance and signals the company's ability to grow profitably despite a complex insurance market. We'll explore how this improved profitability adds a new dimension to Baloise's investment narrative in light of analysts' prior expectations. Find...
SWX:TECN
SWX:TECNLife Sciences

Will Tecan's Leadership Transition Reveal the Strength of Its Growth Strategy? (SWX:TECN)

Tecan Group recently announced that Ralf Griebel, Head of the Partnering Business division and Management Board member since April 2020, has left the company, with Monica Manotas stepping in as interim leader to drive closer business collaboration. This leadership change in a core division highlights both succession planning and the company's ongoing efforts to maintain operational stability during executive transitions. We will assess how the shift in leadership for the Partnering Business...
SWX:LONN
SWX:LONNLife Sciences

Lonza Group (SWX:LONN) Valuation in Focus Following Major Executive Appointments

A big shake-up is underway at Lonza Group (SWX:LONN). The company just announced two senior leadership appointments that could set the stage for its next chapter. Jason Berndt is stepping in as Head of Group Operations and Executive Vice President, while Maria Soler Nunez will become Chief Quality Officer. Both bring a wealth of pharmaceutical and operations expertise from global industry heavyweights. This signals that Lonza is doubling down on strengthening its execution and quality...
SWX:SHLTN
SWX:SHLTNHealthcare

3 European Penny Stocks With Market Caps Under €100M

Amidst rising expectations of a U.S. Federal Reserve rate cut, European markets have shown resilience, with major stock indexes experiencing gains. In this context, the allure of penny stocks—often smaller or newer companies—remains intact as they continue to represent potential growth opportunities for investors seeking alternatives beyond established names. While the term 'penny stocks' may seem outdated, their relevance persists when these companies demonstrate financial strength and offer...
SWX:ADEN
SWX:ADENProfessional Services

Does Adecco Present an Opportunity After Shares Slide 12% Amid Market Volatility?

Thinking about what to do with Adecco Group stock? You are not alone. With shares closing most recently at 22.64, this is the kind of moment that gets investors reaching for their calculators. It has been a mixed ride over the past year, down 12.4% on a 12-month view and off 36.4% from five years ago. However, there is a glimmer of positivity too, with a 1.6% return so far this year. The last month has been especially tough with a 12.9% drop, which follows a wider market trend as investors...